Exhibit 99.2

 

MRI INTERVENTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

    March 31,
2017		     Pro Forma
Adjustments		    

Pro Forma

March 31, 2017

  
ASSETS                      
Current Assets:                      
Cash and cash equivalents   $ 1,969,597   $ 12,068,105 (1)   $ 14,037,702  
Accounts receivable      1,009,775              1,009,775  
Inventory, net      1,809,020              1,809,020  
Prepaid expenses and other current assets      95,625              95,625  
Total current assets      4,884,017     12,068,105       16,952,122  
Property and equipment, net      383,534              383,534  
Software license inventory      906,900              906,900  
Other assets      16,300              16,300  
Total assets   $ 6,190,751   $ 12,068,105     $ 18,258,856  
                       
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                      
Current liabilities:                      
Accounts payable   $  1,308,056   $       $  1,308,056  
Accrued compensation      811,951              811,951  
Other accrued liabilities      618,839             618,839  
Derivative liabilities      224,219     252,919 (2)     477,138  
Deferred product and service revenues      263,097             263,097  
Total current liabilities      3,226,162     252,919       3,479,081  
Accrued interest     577,125             577,125  
Senior secured note payable     2,000,000             2,000,000  
2014 junior secured notes payable, net of unamortized discount and deferred issuance costs     1,814,312             1,814,312  
2010 junior secured notes payable, net of unamortized discount     778,064             778,064  
Total liabilities      8,395,663     252,919       8,648,582  
Commitments and contingencies                      
Stockholders’ deficit:                      
Preferred stock     –             –  
Common stock     36,220     66,250 (1)     102,470  
Additional paid-in capital      93,283,370     12,001,855 (1)     105,285,225  
Accumulated deficit     (95,524,502 )   (252,919 )(2)     (95,777,421 )
Total stockholders’ equity (deficit)     (2,204,912 )   11,815,186       9,610,274  
Total liabilities and stockholders’ equity (deficit)   $  6,190,751   $ 12,068,105     $ 18,258,856  

 

(1)Reflects the receipt of net proceeds of $12,068,105 in the Financing Transaction.
(2)Reflects the change in value of certain common stock warrants accounted for as derivative liabilities due to their net-cash settlement provisions, which provisions were triggered by the Financing Transaction.